New analysis of 13,560 patients demonstrates decisiondx®-melanoma stratifies risk across histological subtypes; findings to be presented at fall clinical dermatology conference

Castle is presenting data on decisiondx®-melanoma and its pipeline atopic dermatitis (ad) test at the 25th annual fall clinical dermatology conference.

CSTL Ratings Summary

CSTL Quant Ranking